share_log
Reuters ·  Mar 17 12:00
Xeris Announces Approval of Supplemental New Drug Application (Snda) of Gvoke Vialdx™ (Glucagon) for Use as a Diagnostic Aid
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 282

Recommended

Write a comment